Journal articles on the topic 'CD20 antibodies'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'CD20 antibodies.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Fuh, Franklin, Reina Fuji, Kirsten A. Poon, Dongwei Li, Clarissa David, Quyen Nguyen, Kathy Howell, et al. "Pharmacodynamic Effects of Administration of Maytansine Conjugated Anti-CD22 Monoclonal Antibodies to Cynomolgus Monkeys." Blood 112, no. 11 (November 16, 2008): 4996. http://dx.doi.org/10.1182/blood.v112.11.4996.4996.
Full textDuperray, C., J. M. Boiron, C. Boucheix, J. F. Cantaloube, T. Lavabre-Bertrand, M. Attal, J. Brochier, D. Maraninchi, R. Bataille, and B. Klein. "The CD24 antigen discriminates between pre-B and B cells in human bone marrow." Journal of Immunology 145, no. 11 (December 1, 1990): 3678–83. http://dx.doi.org/10.4049/jimmunol.145.11.3678.
Full textRymkiewicz, Grzegorz, Renata Woroniecka, Katarzyna Blachnio, Barbara Pienkowska-Grela, and Jan Walewski. "Flow Cytometry and Fluorescence In Situ Hybridization Are Methods of Choice for Routine Diagnosis of Mantle Cell Lymphoma." Blood 106, no. 11 (November 16, 2005): 4659. http://dx.doi.org/10.1182/blood.v106.11.4659.4659.
Full textLones, Mark, and Ivan Kirov. "Cell Surface Targets for Monoclonal Antibody Therapy in Lymphoid Neoplasms of Children and Adolescents." Blood 104, no. 11 (November 16, 2004): 4544. http://dx.doi.org/10.1182/blood.v104.11.4544.4544.
Full textPaiva, Aldair Sousa, Alessandra Suelen Jardim Silva, Victor lima Soares, Gustavo Henrique de Medeiros Oliveira, Lenilton Silva DA Silva Júnior, Hugo Henrique de Freitas Ferreira, Rodrigo Villar Freitas, et al. "Importance of Flow Cytometry in the Differential Diagnosis of Hairy Cell Leukemia in the State of Rio Grande Do Norte, Brazil." Blood 136, Supplement 1 (November 5, 2020): 14–15. http://dx.doi.org/10.1182/blood-2020-143225.
Full textGeisler, CH, JK Larsen, NE Hansen, MM Hansen, BE Christensen, B. Lund, H. Nielsen, T. Plesner, K. Thorling, and E. Andersen. "Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia." Blood 78, no. 7 (October 1, 1991): 1795–802. http://dx.doi.org/10.1182/blood.v78.7.1795.1795.
Full textGeisler, CH, JK Larsen, NE Hansen, MM Hansen, BE Christensen, B. Lund, H. Nielsen, T. Plesner, K. Thorling, and E. Andersen. "Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia." Blood 78, no. 7 (October 1, 1991): 1795–802. http://dx.doi.org/10.1182/blood.v78.7.1795.bloodjournal7871795.
Full textEscribano, Luis, Alberto Orfao, Jesús Villarrubia, Beatriz Díaz-Agustín, Carlos Cerveró, Agustín Rios, José L. Velasco, Juana Ciudad, José L. Navarro, and Jesús F. San Miguel. "Immunophenotypic Characterization of Human Bone Marrow Mast Cells. A Flow Cytometric Study of Normal and Pathological Bone Marrow Samples." Analytical Cellular Pathology 16, no. 3 (1998): 151–59. http://dx.doi.org/10.1155/1998/341340.
Full textWeitzman, James, Monica Betancur, Laurent Boissel, Arthur P. Rabinowitz, and Hans Klingemann. "Variable Contribution of Different Monocloncal Antibodies to NK Cell-Mediated ADCC Against Primary CLL Cells." Blood 110, no. 11 (November 16, 2007): 4715. http://dx.doi.org/10.1182/blood.v110.11.4715.4715.
Full textKusakabe, Manabu, Guillermo Simkin, Justin Meskas, Chaoran Zhang, Daisuke Ennishi, Merrill Boyle, David W. Scott, et al. "Single Cell Mass Cytometry for Phenotypic Analysis of Diffuse Large B-Cell Lymphoma." Blood 124, no. 21 (December 6, 2014): 2976. http://dx.doi.org/10.1182/blood.v124.21.2976.2976.
Full textQu, Zhengxing, David M. Goldenberg, Thomas M. Cardillo, Victoria Shi, Hans J. Hansen, and Chien-Hsing Chang. "Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action." Blood 111, no. 4 (February 15, 2008): 2211–19. http://dx.doi.org/10.1182/blood-2007-08-110072.
Full textChuksina, J. J., E. V. Kataeva, and T. A. Mitina. "Features of immunophenotypic finding B-cell lymphoproliferative diseases by flow cytometry." Kazan medical journal 101, no. 1 (February 11, 2020): 145–52. http://dx.doi.org/10.17816/kmj2020-145.
Full textJabbour, Elias, Susan O’Brien, Farhad Ravandi, and Hagop Kantarjian. "Monoclonal antibodies in acute lymphoblastic leukemia." Blood 125, no. 26 (June 25, 2015): 4010–16. http://dx.doi.org/10.1182/blood-2014-08-596403.
Full textPaietta, Elisabeth, Xiaochun Li, Sue Richards, Janis Racevskis, Gordon W. Dewald, Jacob M. Rowe, Martin S. Tallman, et al. "Implications for the Use of Monoclonal Antibodies in Future Adult ALL Trials: Analysis of Antigen Expression in 505 B-Lineage (B-Lin) ALL Patients (pts) on the MRC UKALLXII/ECOG2993 Intergroup Trial." Blood 112, no. 11 (November 16, 2008): 1907. http://dx.doi.org/10.1182/blood.v112.11.1907.1907.
Full textChang, Chien-Hsing, Edmund A. Rossi, and David M. Goldenberg. "Monoclonal antibodies targeting CD20." mAbs 5, no. 3 (May 2013): 335–36. http://dx.doi.org/10.4161/mabs.24106.
Full textAmu, Sylvie, and Mikael Brisslert. "Phenotype and Function of CD25-Expressing B Lymphocytes Isolated from Human Umbilical Cord Blood." Clinical and Developmental Immunology 2011 (2011): 1–9. http://dx.doi.org/10.1155/2011/481948.
Full textLoken, MR, VO Shah, KL Dattilio, and CI Civin. "Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development." Blood 70, no. 5 (November 1, 1987): 1316–24. http://dx.doi.org/10.1182/blood.v70.5.1316.1316.
Full textLoken, MR, VO Shah, KL Dattilio, and CI Civin. "Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development." Blood 70, no. 5 (November 1, 1987): 1316–24. http://dx.doi.org/10.1182/blood.v70.5.1316.bloodjournal7051316.
Full textSantos, Marcelo Antônio Oliveira, and Marinus de Moraes Lima. "CD20 role in pathophysiology of Hodgkin’s disease." Revista da Associação Médica Brasileira 63, no. 9 (2017): 810–13. http://dx.doi.org/10.1590/1806-9282.63.09.810.
Full textPaiva, Aldair Sousa, Alessandra Suelen Jardim Silva, Lenilton Silva DA Silva Júnior, Gustavo Henrique de Medeiros Oliveira, Hugo Henrique de Freitas Ferreira, Maria das Graças Pereira Araujo, Victor lima Soares, et al. "Importance of Flow Cytometry in the Immunophenotyping Characterization of Mantle Cell Lymphoma in State of Rio Grande Do Norte, Brazil." Blood 136, Supplement 1 (November 5, 2020): 15. http://dx.doi.org/10.1182/blood-2020-143328.
Full textJiao, Cheng, and P. A. Zeynalova. "Prognostically significant bone marrow cellular content changes in diffuse large B-cell lymphoma." Russian Journal of Biotherapy 17, no. 4 (January 11, 2019): 58–63. http://dx.doi.org/10.17650/1726-9784-2018-17-4-58-63.
Full textTuraj, Anna H., Vikki L. Field, Claude H. T. Chan, Christine A. Penfold, Jinny H. Kim, Sonya James, Kerry L. Cox, et al. "Anti-CD27 Enhances Lymphoma Immunotherapy through Profound Myeloid Cell Recruitment." Blood 128, no. 22 (December 2, 2016): 3024. http://dx.doi.org/10.1182/blood.v128.22.3024.3024.
Full textRossi, Edmund A., Rosana Michel, Chien-Hsing Chang, and David M. Goldenberg. "Bispecific Hexavalant Antibodies With Enhanced Trogocytosis For Treatment Of Lupus." Blood 122, no. 21 (November 15, 2013): 2282. http://dx.doi.org/10.1182/blood.v122.21.2282.2282.
Full textMishima, Yuji, Yasuhito Terui, Kengo Takeuchi, Yuko Mishima, and Kiyohiko Hatake. "Characterization of Mechanisms for Acquiring Resistant Phenotype Using a Novel Screening Strategy for Detecting Rituximab-Resistant Mutations." Blood 120, no. 21 (November 16, 2012): 1550. http://dx.doi.org/10.1182/blood.v120.21.1550.1550.
Full textBrauner, Jonathan, Ingrid Beukinga, Zoulikha Amraoui, Zaina Kassengera, Michel Toungouz, and Olivier Pradier. "Flow Cytometry Primary 10 Colours Panel for Chronic Lympho Proliferative Diseases Diagnosis." Blood 118, no. 21 (November 18, 2011): 5190. http://dx.doi.org/10.1182/blood.v118.21.5190.5190.
Full textSapra, Puja, Gary Kikuchi, Ashwini Venkatasamy, Marianne K. Hayes, Christina M. Satterwhite, Darren Warren, Mark D. Walker, David M. Goldenberg, and Ivan D. Horak. "Preclinical Pharmacology and Toxicology of Humanized Anti-B-Cell Antibodies (Anti-CD22 and Anti-CD20) in Cynomolgus Monkeys (CM)." Blood 106, no. 11 (November 16, 2005): 1471. http://dx.doi.org/10.1182/blood.v106.11.1471.1471.
Full textNiederfellner, Gerhard J., Alfred Lammens, Manfred Schwaiger, Guy Georges, Kornelius Wiechmann, Andreas Franke, Wolfgang Schaefer, et al. "Crystal Structure Analysis Reveals That the Novel Type II Anti-CD20 Antibody GA101 Interacts with a Similar Epitope as Rituximab and Ocrelizumab but in a Fundamentally Different Way." Blood 114, no. 22 (November 20, 2009): 3726. http://dx.doi.org/10.1182/blood.v114.22.3726.3726.
Full textRossi, Edmund A., Chien-Hsing Chang, Thomas M. Cardillo, Rhona Stein, Diana Pilas, Diane L. Nordstrom, John Kopinski, and David M. Goldenberg. "Bispecific Anti-CD20/Anti-CD22 Antibodies with Potent Lymphoma Cytotoxicity." Blood 112, no. 11 (November 16, 2008): 1591. http://dx.doi.org/10.1182/blood.v112.11.1591.1591.
Full textBazinet, Alexandre, Ryan N. Rys, Claudia M. Wever, Amadou Barry, Celia Greenwood, Christian Young, Alma Mendoza, et al. "A 10-Color Flow Cytometry Panel for Both Diagnosis and Minimal Residual Disease Measurement in Chronic Lymphocytic Leukemia." Blood 134, Supplement_1 (November 13, 2019): 5451. http://dx.doi.org/10.1182/blood-2019-123904.
Full textCassano, Carlos, Swetlana Mactier, Stephen P. Mulligan, Larissa Belov, Pauline Huang, and Richard I. Christopherson. "Cladribine and Fludarabine Nucleoside Change the Levels of CD Antigens on B-Lymphoproliferative Disorders." International Journal of Proteomics 2010 (May 5, 2010): 1–9. http://dx.doi.org/10.1155/2010/964251.
Full textNiederfellner, Gerhard, Alfred Lammens, Olaf Mundigl, Guy J. Georges, Wolfgang Schaefer, Manfred Schwaiger, Andreas Franke, et al. "Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies." Blood 118, no. 2 (July 14, 2011): 358–67. http://dx.doi.org/10.1182/blood-2010-09-305847.
Full textNalivaiko, Kristina, Martin Hofmann, Ludger Grosse-Hovest, Peter H. Krammer, Hans-Georg Rammensee, Helmut R. Salih, and Gundram Jung. "Inhibition of Antibody Production in Vitro with Bispecific CD20 X CD95 Antibodies." Blood 118, no. 21 (November 18, 2011): 1114. http://dx.doi.org/10.1182/blood.v118.21.1114.1114.
Full textMason, DY, H. Stein, J. Gerdes, KA Pulford, E. Ralfkiaer, B. Falini, WN Erber, K. Micklem, and KC Gatter. "Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells." Blood 69, no. 3 (March 1, 1987): 836–40. http://dx.doi.org/10.1182/blood.v69.3.836.836.
Full textMason, DY, H. Stein, J. Gerdes, KA Pulford, E. Ralfkiaer, B. Falini, WN Erber, K. Micklem, and KC Gatter. "Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells." Blood 69, no. 3 (March 1, 1987): 836–40. http://dx.doi.org/10.1182/blood.v69.3.836.bloodjournal693836.
Full textRossi, Edmund A., David M. Goldenberg, Thomas M. Cardillo, Rhona Stein, and Chien-Hsing Chang. "Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma." Blood 113, no. 24 (June 11, 2009): 6161–71. http://dx.doi.org/10.1182/blood-2008-10-187138.
Full textGerasimova, E., D. Tabakov, A. Aleksankin, R. Shayakhmetova, T. Popkova, and A. Avdeeva. "AB0032 CHARACTERIZATION OF PERIPHERAL BLOOD B-CELL SUBSET IN UNTREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND SYSTEMIC SCLEROSIS." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1150.2–1151. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3739.
Full textvan Oers, Marinus H. J. "CD20 antibodies: type II to tango?" Blood 119, no. 22 (May 31, 2012): 5061–63. http://dx.doi.org/10.1182/blood-2012-04-420711.
Full textCragg, Mark S. "CD20 antibodies: doing the time warp." Blood 118, no. 2 (July 14, 2011): 219–20. http://dx.doi.org/10.1182/blood-2011-04-346700.
Full textGopal, Ajay K., and Oliver W. Press. "Clinical applications of anti-CD20 antibodies." Journal of Laboratory and Clinical Medicine 134, no. 5 (November 1999): 445–50. http://dx.doi.org/10.1016/s0022-2143(99)90164-6.
Full textKlein, Christian, Alfred Lammens, Wolfgang Schäfer, Guy Georges, Manfred Schwaiger, Ekkehard Mössner, Karl-Peter Hopfner, Pablo Umaña, and Gerhard Niederfellner. "Response to: Monoclonal antibodies targeting CD20." mAbs 5, no. 3 (May 2013): 337–38. http://dx.doi.org/10.4161/mabs.24108.
Full textMishima, Yuji, Yasuhito Terui, Yuko Mishima, and Kiyohiko Hatake. "Anti-N-Terminal CD20 Monoclonal Antibody and L26 Dual Staining Identifies An Irreversible Resistant Mutant Genes." Blood 116, no. 21 (November 19, 2010): 4145. http://dx.doi.org/10.1182/blood.v116.21.4145.4145.
Full textKumar, Anand, Cyril Planchais, Rémi Fronzes, Hugo Mouquet, and Nicolas Reyes. "Binding mechanisms of therapeutic antibodies to human CD20." Science 369, no. 6505 (August 13, 2020): 793–99. http://dx.doi.org/10.1126/science.abb8008.
Full textGordeychuk, I. V., A. I. Tukhvatulin, S. P. Petkov, M. A. Abakumov, S. A. Gulyaev, N. M. Tukhvatulina, T. V. Gulyaeva, M. I. Mikhaylov, D. Y. Logunov, and M. G. Isaguliants. "Assessment of the Parameters of Adaptive Cell-Mediated Immunity in Naïve Common Marmosets (Callithrix jacchus)." Acta Naturae 10, no. 4 (December 15, 2018): 63–69. http://dx.doi.org/10.32607/20758251-2018-10-4-63-69.
Full textHabermann, Thomas M. "Antibody Therapy in Aggressive Lymphomas." Hematology 2007, no. 1 (January 1, 2007): 257–64. http://dx.doi.org/10.1182/asheducation-2007.1.257.
Full textVilventhraraja, Emma, Tetyana Klymenko, Jennifer Edelmann, John Gribben, and Andrejs Ivanov. "Reduction of Mitochondrial Membrane Potential Leads to Enhancement of Type-II CD20-Antibody Cytotoxicity in Diffuse Large B-Cell Lymphoma." Blood 128, no. 22 (December 2, 2016): 1763. http://dx.doi.org/10.1182/blood.v128.22.1763.1763.
Full textKretschmer, Anna, Stefan Lohse, Thies Rösner, Marco J. H. Jansen, Christian Kellner, Matthias Peipp, Mark S. Cragg, et al. "CD20 Antibodies of Human IgA Isotype Mediate CDC, and ADCC By Myeloid Effector Cells." Blood 128, no. 22 (December 2, 2016): 1835. http://dx.doi.org/10.1182/blood.v128.22.1835.1835.
Full textQu, Zhengxing, Thomas M. Cardillo, Victoria Shi, Diana L. Delaney, Hans J. Hansen, Chien-Hsing Chang, and David M. Goldenberg. "Recombinant Bispecific Monoclonal Antibody (bsMAb) Against CD20 and CD22 Active In Vitro and In Vivo Against B-Cell Lymphomas." Blood 108, no. 11 (November 16, 2006): 2521. http://dx.doi.org/10.1182/blood.v108.11.2521.2521.
Full textLuong, Quang Trong, Kouki Morizono, Irvin SY Chen, and Sven De Vos. "Construction of Lentiviruses Pseudotyped with Sindbis E2-Single Chain Antibody (SCA) Fusions or Membrane-Anchored SCAs for Targeted Therapies in Lymphoma." Blood 114, no. 22 (November 20, 2009): 3571. http://dx.doi.org/10.1182/blood.v114.22.3571.3571.
Full textSharman, Jeff P. "Targeting CD20: teaching an old dog new tricks." Hematology 2019, no. 1 (December 6, 2019): 273–78. http://dx.doi.org/10.1182/hematology.2019000031.
Full textNewell, Laura, Joseph Tuscano, Yunpeng Ma, Shiloh Martin, and Robert o'Donnell. "The Bispecific Anti-CD20/CD22 Antibody (Bs20x22) Has More Lymphomacidal Activity Than the Parent Antibodies Both Alone or In Combination." Blood 116, no. 21 (November 19, 2010): 425. http://dx.doi.org/10.1182/blood.v116.21.425.425.
Full text